Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R OinonenErkki Elonen

Abstract

Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodgkin's lymphoma recently recognised as a distinct disease entity. Little is known about the prognostic factors and optimal treatment of MCL. The aim of this study was to analyse retrospectively the clinical features and effect of treatment in 94 MCL patients diagnosed and treated in one centre between 1980 and 1996, and to find out different factors influencing the treatment results and prognosis. The median age of the patients was 66 years, and 77% were over 60 years old. Of the patients, 76% had advanced disease, the performance status (PS) was WHO 0-1 in 86%, and B symptoms were present in 35% of the cases. Bone marrow infiltration was found in 61% and overt leukaemia in 12% of the patients. Of the patients, 47% achieved complete remission with first- or second-line therapy. The median duration of remission, time to treatment failure (TTF), and survival were 28, 18, and 41 months, respectively. In multivariate analyses, age, stage and leukaemic disease were significantly associated with TTF, and age, stage, leukaemic disease and lactate dehydrogenase (LDH) with survival. Long-term prognosis is poor in MCL. None of the conventional chemotherapies seems curative. A prosp...Continue Reading

References

Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Aug 12, 1993·The New England Journal of Medicine·M S KaminskiG M Butchko
Jan 1, 1995·Histopathology·S PittalugaC de Wolf-Peeters
Jun 1, 1994·Blood Reviews·E Vandenberghe
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Mar 30, 1999·Advances in Anatomic Pathology·P J Kurtin
Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J M VoseJ O Armitage

❮ Previous
Next ❯

Citations

Feb 5, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R RätyE Elonen
Oct 3, 1999·Current Opinion in Oncology·P McLaughlin
Jul 10, 1999·Current Opinion in Hematology·R G Bociek, J O Armitage
Sep 27, 2006·The American Journal of Surgical Pathology·Antonio SalarSergio Serrano
Jan 15, 2005·Blood·Irene M GhobrialThomas E Witzig
Oct 27, 2007·Blood·Eva HosterUNKNOWN European Mantle Cell Lymphoma Network
Mar 10, 2010·Drugs & Aging·Paolo F CaimiHillard M Lazarus
Feb 27, 2009·Future Oncology·Elena M HartmannAndreas Rosenwald
Mar 21, 2002·The Lancet Oncology·I BaristaF Cabanillas
Apr 16, 2002·European Journal of Haematology·Maria K AngelopoulouGerassimos A Pangalis
Apr 30, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Caroline Bodet-MilinSteven Le Gouill
Sep 26, 2008·La Revue de médecine interne·G MohamedA Ghorbel
Apr 16, 2008·British Journal of Haematology·Pedro Jares, Elías Campo
Mar 4, 2006·British Journal of Haematology·M B MøllerB E Christensen
May 24, 2012·Leukemia & Lymphoma·Eliza A HawkesDavid Cunningham
Aug 3, 2002·Leukemia & Lymphoma·Didier Decaudin
Aug 27, 2002·Cytotherapy·S M SmithK van Besien
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annina HerrmannMartin Dreyling
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Orion M HowardMargaret A Shipp
Jun 18, 2004·Leukemia·P Korkolopoulou, T P Vassilakopoulos
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FreyerV Trillet-Lenoir
Jun 22, 2000·American Journal of Hematology·D D WeisenburgerJ O Armitage
May 9, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Tom KouroukisUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 23, 2021·Anais Brasileiros De Dermatologia·Mariana Righetto de RéSilvio Alencar Marques
Dec 3, 1999·Archives of Pathology & Laboratory Medicine·R C Hankin, S V Hunter

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.